167 related articles for article (PubMed ID: 15735806)
41. Comparison of on-treatment platelet reactivity between triple antiplatelet therapy with cilostazol and standard dual antiplatelet therapy in patients undergoing coronary interventions: a meta-analysis.
Panchal HB; Shah T; Patel P; Albalbissi K; Molnar J; Coffey B; Khosla S; Ramu V
J Cardiovasc Pharmacol Ther; 2013 Nov; 18(6):533-43. PubMed ID: 23872509
[TBL] [Abstract][Full Text] [Related]
42. Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin.
Duzenli MA; Ozdemir K; Aygul N; Soylu A; Tokac M
Am J Cardiol; 2008 Aug; 102(4):396-400. PubMed ID: 18678294
[TBL] [Abstract][Full Text] [Related]
43. Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.
Tetik S; Ak K; Isbir S; Eksioglu-Demiralp E; Arsan S; Iqbal O; Yardimci T
Clin Appl Thromb Hemost; 2010 Apr; 16(2):189-98. PubMed ID: 19703819
[TBL] [Abstract][Full Text] [Related]
44. Short- versus long-term duration of dual antiplatelet therapy in patients treated for in-stent restenosis: a PRODIGY trial substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia).
Campo G; Tebaldi M; Vranckx P; Biscaglia S; Tumscitz C; Ferrari R; Valgimigli M
J Am Coll Cardiol; 2014 Feb; 63(6):506-12. PubMed ID: 24161321
[TBL] [Abstract][Full Text] [Related]
45. Delayed thrombin-induced platelet-fibrin clot generation by clopidogrel: a new dose-related effect demonstrated by thrombelastography in patients undergoing coronary artery stenting.
Gurbel PA; Bliden KP; Guyer K; Aggarwal N; Tantry US
Thromb Res; 2007; 119(5):563-70. PubMed ID: 16806409
[TBL] [Abstract][Full Text] [Related]
46. NCX4016: a novel antithrombotic agent.
Gresele P; Momi S; Mezzasoma AM
Dig Liver Dis; 2003 May; 35 Suppl 2():S20-6. PubMed ID: 12846440
[TBL] [Abstract][Full Text] [Related]
47. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM
Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328
[TBL] [Abstract][Full Text] [Related]
48. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
[TBL] [Abstract][Full Text] [Related]
49. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.
Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y
Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624
[TBL] [Abstract][Full Text] [Related]
50. Response to aspirin and clopidogrel monitored with different platelet function methods.
Mani H; Linnemann B; Luxembourg B; Kirchmayr K; Lindhoff-Last E
Platelets; 2006 Aug; 17(5):303-10. PubMed ID: 16928602
[TBL] [Abstract][Full Text] [Related]
51. Spaced administration of PA32540 and clopidogrel results in greater platelet inhibition than synchronous administration of enteric-coated aspirin and enteric-coated omeprazole and clopidogrel.
Gurbel PA; Bliden KP; Fort JG; Jeong YH; Shuldiner A; Chai S; Gesheff T; Antonino M; Gesheff M; Zhang Y; Tantry US
Am Heart J; 2013 Feb; 165(2):176-82. PubMed ID: 23351820
[TBL] [Abstract][Full Text] [Related]
52. Comparison of platelet reactivity and clopidogrel response in patients ≤ 75 Years Versus > 75 years undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome.
Cuisset T; Quilici J; Grosdidier C; Fourcade L; Gaborit B; Pankert M; Molines L; Morange PE; Bonnet JL; Alessi MC
Am J Cardiol; 2011 Nov; 108(10):1411-6. PubMed ID: 21872198
[TBL] [Abstract][Full Text] [Related]
53. Measurement of shear-activated platelet aggregate formation in non-anticoagulated blood: utility in detection of clopidogrel-aspirin-induced platelet dysfunction.
Johnson GJ; Sharda AV; Rao GH; Ereth MH; Laxson DD; Owen WG
Clin Appl Thromb Hemost; 2012; 18(2):140-9. PubMed ID: 22009986
[TBL] [Abstract][Full Text] [Related]
54. Determination of the prevalence of aspirin and clopidogrel resistances in patients with coronary artery disease by using various platelet-function tests.
Woo KS; Kim BR; Kim JE; Goh RY; Yu LH; Kim MH; Han JY
Korean J Lab Med; 2010 Oct; 30(5):460-8. PubMed ID: 20890076
[TBL] [Abstract][Full Text] [Related]
55. Platelet aggregometry and receptor binding to predict the magnitude of antithrombotic and bleeding time effects of clopidogrel in rabbits.
Wong PC; Crain EJ; Watson CA; Jiang X; Hua J; Bostwick JS; Ogletree ML; Schumacher WA; Rehfuss R
J Cardiovasc Pharmacol; 2007 May; 49(5):316-24. PubMed ID: 17513951
[TBL] [Abstract][Full Text] [Related]
56. Optimizing platelet P2Y12 inhibition for patients undergoing PCI.
Steinhubl S; Roe MT
Cardiovasc Drug Rev; 2007; 25(2):188-203. PubMed ID: 17614940
[TBL] [Abstract][Full Text] [Related]
57. Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates.
Harker LA; Marzec UM; Kelly AB; Chronos NR; Sundell IB; Hanson SR; Herbert JM
Circulation; 1998 Dec; 98(22):2461-9. PubMed ID: 9832493
[TBL] [Abstract][Full Text] [Related]
58. Effects of aspirin and clopidogrel versus oral anticoagulation on platelet function and on coagulation in patients with nonvalvular atrial fibrillation (CLAFIB).
Müller I; Massberg S; Zierhut W; Binz C; Schuster A; Rüdiger-von Hoch S; Braun S; Gawaz M
Pathophysiol Haemost Thromb; 2002; 32(1):16-24. PubMed ID: 12214159
[TBL] [Abstract][Full Text] [Related]
59. The Pharmacogenomics of Anti-Platelet Intervention (PAPI) Study: Variation in Platelet Response to Clopidogrel and Aspirin.
Bozzi LM; Mitchell BD; Lewis JP; Ryan KA; Herzog WR; O'Connell JR; Horenstein RB; Shuldiner AR; Yerges-Armstrong LM
Curr Vasc Pharmacol; 2016; 14(1):116-24. PubMed ID: 26374108
[TBL] [Abstract][Full Text] [Related]
60. Differential effects of esomeprazole on the antiplatelet activity of clopidogrel in healthy individuals and patients after coronary stent implantation.
Zhang R; Ran HH; Zhu HL; Chen Q
J Int Med Res; 2010; 38(5):1617-25. PubMed ID: 21309475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
